ANALYSIS OF 2ND-SITE REVERTANTS OF A MURINE CORONAVIRUS NUCLEOCAPSID PROTEIN DELETION MUTANT AND CONSTRUCTION OF NUCLEOCAPSID PROTEIN MUTANTS BY TARGETED RNA RECOMBINATION

The Alb4 mutant of the coronavirus mouse hepatitis virus (MHV) is both temperature sensitive and thermolabile owing to a deletion in the gene encoding its nucleocapsid (N) protein, The deletion removes 29 amino acids that constitute a putative spacer region preceding the carboxyl-terminal domain of the protein. As a step toward understanding the structure and function of the MHV N protein, we isolated multiple independent revertants of Alb4 that totally or partially regained the ability to form large (wild-type-sized) plaques at the nonpermissive temperature. The N proteins of these revertant viruses concomitantly regained the ability to bind to RNA in vitro at a temperature that was restrictive for RNA binding by Alb4 N protein. Sequence analysis of the N genes of the revertants revealed that each contained a single second-site point mutation that compensated for the effects of the deletion. All reverting mutations were clustered within a stretch of 40 amino acids centered some 80 residues on the amino side of the Alb4 deletion, within a domain to which the RNA-binding activity of N had been previously mapped. By means of a targeted RNA recombination method that we have recently developed, two of the reverting mutations were introduced into a wild-type MHV genomic background; The resulting recombinants were stable and shelved no gross phenotypic differences from the wild type, A detailed analysis of one, however, revealed that it was at a selective disadvantage with respect to the wild type.